- Home
- MUA vs TOI Comparison
MUA vs TOI Comparison
Compare MUA & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUA
- TOI
- Stock Information
- Founded
- MUA 1993
- TOI 2007
- Country
- MUA United States
- TOI United States
- Employees
- MUA N/A
- TOI N/A
- Industry
- MUA Investment Bankers/Brokers/Service
- TOI Medical/Nursing Services
- Sector
- MUA Finance
- TOI Health Care
- Exchange
- MUA Nasdaq
- TOI Nasdaq
- Market Cap
- MUA 427.1M
- TOI 393.4M
- IPO Year
- MUA N/A
- TOI N/A
- Fundamental
- Price
- MUA $10.74
- TOI $3.95
- Analyst Decision
- MUA
- TOI Strong Buy
- Analyst Count
- MUA 0
- TOI 1
- Target Price
- MUA N/A
- TOI $6.00
- AVG Volume (30 Days)
- MUA 92.6K
- TOI 1.7M
- Earning Date
- MUA 01-01-0001
- TOI 11-12-2025
- Dividend Yield
- MUA 4.84%
- TOI N/A
- EPS Growth
- MUA N/A
- TOI N/A
- EPS
- MUA N/A
- TOI N/A
- Revenue
- MUA N/A
- TOI $424,376,000.00
- Revenue This Year
- MUA N/A
- TOI $21.71
- Revenue Next Year
- MUA N/A
- TOI $20.58
- P/E Ratio
- MUA N/A
- TOI N/A
- Revenue Growth
- MUA N/A
- TOI 17.53
- 52 Week Low
- MUA $8.61
- TOI $0.13
- 52 Week High
- MUA $11.43
- TOI $4.50
- Technical
- Relative Strength Index (RSI)
- MUA 40.49
- TOI 63.26
- Support Level
- MUA $10.51
- TOI $3.75
- Resistance Level
- MUA $11.14
- TOI $4.08
- Average True Range (ATR)
- MUA 0.19
- TOI 0.21
- MACD
- MUA -0.08
- TOI 0.06
- Stochastic Oscillator
- MUA 24.74
- TOI 87.03
About MUA Blackrock MuniAssets Fund Inc
Blackrock Muniassets Fund Inc is a closed-end fund. Its objective is to provide high current income exempt from U.S. federal income taxes by investing in a portfolio of medium- to lower-grade or unrated municipal obligations. The Fund invests more of its total assets in municipal bonds.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.